Publicacions (17) Publicacions de Olga López Villar

2022

  1. Relationship between ABO Blood Group Distribution and COVID-19 Infection in Patients Admitted to the ICU: A Multicenter Observational Spanish Study

    Journal of Clinical Medicine, Vol. 11, Núm. 11

2020

  1. Agreements and uncertainties in autologous haematopoietic stem cell mobilization and collection. A Spanish consensus document

    Bone Marrow Transplantation, Vol. 55, Núm. 4, pp. 811-817

2019

  1. Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: Results of a prospective phase I/II clinical trial with long-term follow-up

    Stem Cell Research and Therapy, Vol. 10, Núm. 1

2018

  1. International Forum on GMP-grade human platelet lysate for cell propagation

    Vox Sanguinis, Vol. 113, Núm. 1, pp. e1-e25

2014

  1. Results of allogeneic stem cell transplantation in the Spanish MDS registry: Prognostic factors for low risk patients

    Leukemia Research, Vol. 38, Núm. 10, pp. 1199-1206

  2. Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease

    Biology of Blood and Marrow Transplantation, Vol. 20, Núm. 10, pp. 1580-1585

2013

  1. To freeze or not to freeze peripheral blood stem cells prior to allogeneic transplantation from matched related donors

    European Journal of Haematology, Vol. 91, Núm. 5, pp. 448-455

2012

  1. Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation

    Transfusion, Vol. 52, Núm. 5, pp. 1086-1091

  2. Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients

    Haematologica, Vol. 97, Núm. 8, pp. 1218-1224

  3. Unidades de producción celular para investigación clínica con células madre: principios básicos para su establecimiento y optimización

    Medicina Clinica, Vol. 138, Núm. 1, pp. 31-36

2011

  1. Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: Results of a phase I/II clinical trial

    Haematologica, Vol. 96, Núm. 7, pp. 1072-1076

2009

  1. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome

    Leukemia, Vol. 23, Núm. 4, pp. 664-672

  2. C013 Genomic aberrations observed in mesenchymal stem cells from 5q-syndrome could be involved in the pathophysiology of the disease

    Leukemia Research, Vol. 33, Núm. SUPPL. 1

  3. Multiparametric comparison of mesenchymal stromal cells obtained from trabecular bone by using a novel isolation method with those obtained by iliac crest aspiration from the same subjects

    Cell and Tissue Research, Vol. 336, Núm. 3, pp. 501-507

  4. P136 Allogenic stem cell transplant in MDS: results of the Spanish registry

    Leukemia Research, Vol. 33, Núm. SUPPL. 1

2006

  1. Complete remission of subcutaneous panniculitic T-cell lymphoma after allogeneic transplantation [1]

    Bone Marrow Transplantation

  2. Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Acute Graft-versus-Host Disease (GVHD)

    Biology of Blood and Marrow Transplantation, Vol. 12, Núm. 9, pp. 936-941